Cue Biopharma, Inc. (CUE) stock
Close on Nov 12, 2026Market cap $127.13MP/E –Yield –
Cue Biopharma statistics
75 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Q3 FY2026, expected soon
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 55.03
- 2.29
Enterprise valuationIndustry
- EV / Sales
- 2.91
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- 84.0%
- 10.9%
- Shares Change (QoQ)
- 60.6%
- 0.48%
- Float
- 6M
- 49M
- Shares Held by Insiders
- 17.4%
- 12.1%
- Shares Held by Institutions
- 22.6%
- 56.4%
Short sellingIndustry
- Short Interest
- 862,798
- –
- Short Interest Change
- 8.86%
- -0.76%
- Short % of Float
- 14.4%
- 9.06%
- Short % of Shares Outstanding
- 11.9%
- 6.30%
- Days to Cover
- 7.57
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $45.50
- –
- 52-Week Low
- $4.97
- –
- 20-Day Moving Average
- $18.93
- –
- 50-Day Moving Average
- $24.17
- –
- 200-Day Moving Average
- $21.54
- –
- Average True Range (14)
- $2.35
- –
- Price Change (1 Week)
- -2.83%
- 1.51%
- Price Change (1 Month)
- -5.91%
- -2.37%
- Price Change (3 Months)
- -48.8%
- -21.1%
- Price Change (6 Months)
- -30.9%
- -22.8%
- Price Change (YTD)
- 91.0%
- -22.6%
- Price Change (1 Year)
- -14.6%
- -21.0%
- Price Change (3 Years)
- -75.6%
- -24.8%
- Price Change (5 Years)
- -96.5%
- -76.9%
- Average Volume (10 Days)
- 149,066
- –
- Average Volume (20 Days)
- 134,746
- –
- Average Volume (90 Days)
- 236,697
- –
- Relative Volume
- 0.62
- 0.80
- Relative Strength Index (14)
- 40.5
- 44.7
- Volatility (1 Year)
- 202.4%
- 80.2%
- Beta (5 Years)
- 2.36
- 1.07
MarginsIndustry
- EBITDA Margin
- -258.4%
- -27.7%
- FCF Margin
- -133.2%
- -8.85%
Returns on capitalIndustry
- Return on Equity (ROE)
- -1603.5%
- -51.3%
- Return on Assets (ROA)
- -459.6%
- -40.7%
- Return on Capital Employed (ROCE)
- -1039.8%
- -38.1%
Financial positionIndustry
- Current Ratio
- 1.25
- 3.31
- Quick Ratio
- 1.07
- 2.41
GrowthIndustry
- Revenue Growth (YoY)
- 354.4%
- 7.26%
- Revenue Growth (3Y CAGR)
- 180.5%
- 2.25%
- Revenue Growth (5Y CAGR)
- 54.2%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 1.05
- 0.40
- Revenue Per Employee
- $1.30M
- $429.38K
- Profits Per Employee
- -$5.66M
- -$683.67K
- Employee Count
- 29
- 75
- WACC
- 16.7%
- 10.0%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $17.39M
- $16.98M
- Net Cash Per Share
- $2.39
- $0.72
- Equity (Book Value)
- $2.31M
- $52.68M
- Book Value Per Share
- $0.32
- $1.50
- Tangible Book Value
- $2.31M
- $26.74M
- Working Capital
- $5.41M
- $78.52M
Cash flow (TTM)Industry
- Capital Expenditures
- -$121.00K
- -$944.00K
- FCF Per Share
- -$6.91
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -129.1%
- -21.0%
- FCF Yield
- -39.5%
- -9.44%
Scores and fair valueIndustry
- Altman Z-Score
- -30.49
- 0.26
- Piotroski F-Score
- 5
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | CUE | S&P 500 | Difference | CUE per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -28.9% | -2.7% | −26.2 pts | ||
| 3 months | -42.5% | -1.7% | −40.7 pts | ||
| Year to date | +91.0% | +11.9% | +79.1 pts | ||
| 1 year | -12.6% | +12.0% | −24.6 pts | ||
| 3 years | -74.7% | +78.2% | −152.9 pts | -36.8% | +21.2% |
| 5 years | -96.5% | +73.2% | −169.7 pts | -48.8% | +11.6% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
1M CUE shares were sold short on Oct 30, 2026, up 8.9% from the previous report, or 14.38% of the shares available to trade. At recent volumes it would take 7.6 days to buy them back. Over the last 20 sessions, 56.3% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 862,798 | +8.9% | 113,963 | 7.6 |
| Oct 15, 2026 | 792,553 | +12.9% | 213,851 | 3.7 |
| Sep 30, 2026 | 702,198 | +111.4% | 666,076 | 1.1 |
| Sep 15, 2026 | 332,105 | +4.3% | 136,259 | 2.4 |
| Aug 31, 2026 | 318,420 | -2.8% | 180,671 | 1.8 |
| Aug 14, 2026 | 327,442 | -6.4% | 200,890 | 1.6 |
| Jul 31, 2026 | 349,876 | +13.6% | 184,644 | 1.9 |
| Jul 15, 2026 | 307,891 | +3.3% | 138,660 | 2.2 |
| Jun 30, 2026 | 298,077 | +8.4% | 111,200 | 2.7 |
| Jun 15, 2026 | 274,983 | -1.0% | 73,707 | 3.7 |
| May 29, 2026 | 277,694 | +8.8% | 107,168 | 2.6 |
| May 15, 2026 | 255,157 | -11.7% | 2,034,085 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?